Mechanisms of evasion of neutrophil killing by Anaplasma phagocytophilum

Current Opinion in Hematology

Volumn 13, Issue 1, 2006, Pages 28-33

  Carlyon, Jason A ^a   Fikrig, Erol ^b  

^a UNIVERSITY OF KENTUCKY   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Apoptosis; Human granulocytic anaplasmosis; Human granulocytic ehrlichiosis; Intracellular pathogen; Oxidative killing

Indexed keywords

CASPASE 3; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; TRANSCRIPTION FACTOR; BCL2 RELATED PROTEIN A1; BCL2-RELATED PROTEIN A1; CYBB PROTEIN, HUMAN; CYTOCHROME B; CYTOCHROME B558; MEMBRANE PROTEIN; PROTEIN BCL 2;

ANAPLASMA PHAGOCYTOPHILUM; ANIMAL CELL; APOPTOSIS; CELL COMPARTMENTALIZATION; CELL GRANULE; CELL KILLING; CELL SURVIVAL; EHRLICHIOSIS; ENZYME INHIBITION; GENE EXPRESSION REGULATION; GENETIC MANIPULATION; HOST CELL; MOUSE; NEUTROPHIL; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROMOTER REGION; RESPIRATORY BURST; REVIEW; SECRETORY VESICLE; HUMAN; METABOLISM; MICROBIOLOGY; PATHOGENICITY; PATHOLOGY; SIGNAL TRANSDUCTION;

ANAPLASMA PHAGOCYTOPHILUM; APOPTOSIS; CYTOCHROME B GROUP; EHRLICHIOSIS; HUMANS; MEMBRANE GLYCOPROTEINS; NADPH OXIDASE; NEUTROPHILS; PROTO-ONCOGENE PROTEINS C-BCL-2; SIGNAL TRANSDUCTION;

EID: 33644836708     PISSN: 10656251     EISSN: 15317048     Source Type: Journal    
DOI: 10.1097/01.moh.0000190109.00532.56     Document Type: Review

References (36)

1. Carlyon JA, Fikrig E. Pathogenic strategies of Anaplasma phagocytophilum, a unique bacterium that colonizes neutrophils. In: Gillespie SH, Smith GL, Osbourn A, editors. Sixty-third Symposium of the Society for General Microbiology. University of Bath. Cambridge: Cambridge University Press; 2004. pp. 301-329. This provides a thorough review of A. phagocytophilum pathogenesis, focusing on the P44 gene family, bacteria-host cell interactions, inhibition of endosomal maturation and NADPH oxidase mediated killing, and manipulation of host cell apoptosis and the chemokine response.
2. Goodman JL Human granulocytic anaplasmosis. In: Goodman JL, Dennis DT, Sonenshine DE, editors. Tick-borne diseases of humans. Washington, DC: ASM Press; 2005. pp. 218-238. This is an excellent and comprehensive review of HGA that encompasses the epidemiology, clinical manifestations, laboratory and pathologic findings, differential diagnosis, diagnostic testing, and treatment of the disease. Additionally, the review covers the phylogeny, life cycle, zoonotic transmission, and pathogenesis of A. phagocytophilum.
3. DeLeo FR. Modulation of phagocyte apoptosis by bacterial pathogens. Apoptosis 2004; 9:399-413. This review summarizes the recent findings by this group that uptake of a variety of bacteria and phagocytic stimuli activate an apoptosis differentiation program in neutrophils that is integral to the clearing of infection.
4. Segal AW. How neutrophils kill microbes. Annu Rev Immunol 2005; 23:197-223. This review provides a thorough summary of neutrophil oxidative killing.
5. Herron MJ, Ericson M, Munderloh U. Interactions of Anaplasma phagocytophilum, endothelial cells, and human neutrophils. In: Oteo J, Blanco J, Portillo A, editors. Fourth International Conference on Rickettsiae and Rickettsial Diseases; Logrono, Spain; 18-21 June 2005. Trama Impresores S.A.L.; 2005. This is the first in-vivo demonstration that A. phagocytophilum resides within vascular endothelium in infected mice.
6. Munderloh UG, Lynch MJ, Herron MJ, et al. Infection of endothelial cells with Anaplasma marginale and A. phagocytophilum. Vet Microbiol 2004; 101:53-64. This paper was the first to demonstrate that A. phagocytophilum is capable of infecting and residing within endothelial cell lines.
7. Scorpio DG, Akkoyunlu M, Fikrig E, Dumler JS. CXCR2 blockade influences Anaplasma phagocytophilum propagation but not histopathology in the mouse model of human granulocytic anaplasmosis. Clin Diagn Lab Immunol 2004; 11:963-968. This paper provides in-vivo evidence of the importance of neutrophil chemotatic cytokine signaling in the dissemination of A. phagocytophilum infection.
8. Choi KS, Garyu J, Park J, Dumler JS. Diminished adhesion of Anaplasma phagocytophilum-infected neutrophils to endothelial cells is associated with reduced expression of leukocyte surface selectin. Infect Immun 2003; 71: 4586-4594.
9. Garyu JW, Choi KS, Grab DJ, Dumler JS. Defective phagocytosis in Anaplasma phagocytophilum-infected neutrophils. Infect Immun 2005; 73: 1187-1190. This paper demonstrates that A. phagocytophilum infected neutrophils exhibit reduced phagocytic activity in vitro.
10. Quinn MT, Gauss KA. Structure and regulation of the neutrophil respiratory burst oxidase: comparison with nonphagocyte oxidases. J Leukoc Biol 2004; 76:760-781. This review provides detailed analysis of the individual components that comprise NADPH oxidase and how they are regulated to form the active enzyme complex.
11. Borjesson DL, Kobayashi SD, Whitney AR, et al. Insights into pathogen immune evasion mechanisms: Anaplasma phagocytophilum fails to induce an apoptosis differentiation program in human neutrophils. J Immunol 2005; 174:6364-6372. This outstanding paper was the first of several microarray studies of A. phagocytophilum infected cells. It demonstrated that, unlike that of other bacterial species, uptake of A. phagocytophilum fails to stimulate the neutrophil apoptosis differentiation program and also provided gene profiling data that the bacterium interferes with apoptosis gene expression to delay spontaneous neutrophil apoptosis in vitro.
12. -. Moreover, this paper shows that addition of the bacterium at high concentrations leads to a dose and incubation time-dependent mobilization of NADPH oxidase and neutrophil degranulation that results in a significantly lowered respiratory burst upon secondary stimulation, thus providing an explanation for earlier misinterpretations that the bacterium directly inhibits immediate NADPH oxidase activity.
13. Mott J, Rikihisa Y. Human granulocytic ehrlichiosis agent inhibits superoxide anion generation by human neutrophils. Infect Immun 2000; 68:6697-6703.
14. 558 is A. phagocytophilum vacuole-specific. It also shows that addition of the bacterium to neutrophils does not alter oxygen consumption, which strongly argues for a lack of oxidase stimulation.
15. Mott J, Barnewall RE, Rikihisa Y. Human granulocytic ehrlichiosis agent and Ehrlichia chaffeensis reside in different cytoplasmic compartments in HL-60 cells. Infect Immun 1999; 67:1368-1378.
16. Mott J, Rikihisa Y, Tsunawaki S. Effects of Anaplasma phagocytophila on NADPH oxidase components in human neutrophils and HL-60 cells. Infect Immun 2002; 70:1359-1366.
17. Choi KS, Dumler JS. Early induction and late abrogation of respiratory burst in A. phagocytophilum-infected neutrophils. Ann NY Acad Sci 2003; 990:488-493.
18. ••] that this observation likely stems from mobilization of finite granule stores upon addition of the bacterium.
19. Herron MJ, Goodman JL. Evidence that the human granulocytic ehrlichiosis agent utilizes a novel oxygen radical detoxification system: cytochrome c re-oxidation. In: American Society for Rickettsiology-Bartonella as an emerging pathogen group 2001 joint conference; Big Sky, Montana; 17-21 August 2001. Abstract no. 50.
20. Ohashi N, Zhi N, Lin Q, Rikihisa Y. Characterization and transcriptional analysis of gene clusters for a type IV secretion machinery in human granulocytic and monocytic ehrlichiosis agents. Infect Immun 2002; 70:2128-2138.
21. Wang T, Malawista SE, Pal U, et al. Superoxide anion production during Anaplasma phagocytophila infection. J Infect Dis 2002; 186:274-280.
22. Banerjee R, Anguita J, Roos D, Fikrig E. Infection by the agent of human granulocytic ehrlichiosis prevents the respiratory burst by down-regulating gp91phox. J Immunol 2000; 164:3946-3949.
23. Carlyon JA, Chan WT, Galan J, et al. Repression of rac2 mRNA expression by Anaplasma phagocytophila is essential to the inhibition of superoxide production and bacterial proliferation. J Immunol 2002; 169:7009-7018.
24. phox mRNA expression in HL-60 cells. These are the first data of a pathogen directly altering promoter activity to inhibit gene expression of an NADPH oxidase component.
25. de la Fuente J, Ayoubi P, Blouin EF, et al. Gene expression profiling of human promyelocytic cells in response to infection with Anaplasma phagocytophilum. Cell Microbiol 2005; 7:549-559.
26. Banerjee R, Anguita J, Fikrig E. Granulocytic ehrlichiosis in mice deficient in phagocyte oxidase or inducible nitric oxide synthase. Infect Immun 2000; 68:4361-4362.
27. von Loewenich FD, Scorpio DG, Reischl U, et al. Frontline: control of Anaplasma phagocytophilum, an obligate intracellular pathogen, in the absence of inducible nitric oxide synthase, phagocyte NADPH oxidase, tumor necrosis factor, toll-like receptor (TLR)2 and TLR4, or the TLR adaptor molecule MyD88. Eur J Immunol 2004; 34:1789-1797. This paper evidences that clearance of A. phagocytophilum infection occurs independently of many pathways that normally play key roles in the control of other intracellular pathogens.
28. Byrne GI, Ojcius DM. Chlamydia and apoptosis: life and death decisions of an intracellular pathogen. Nat Rev Microbiol 2004; 2:802-808. This provides an excellent summary of the regulation of apoptosis and the effects of the obligate intracellular bacteria, Chlamydia spp., on host cell apoptosis.
29. Danial NN, Korsmeyer SJ. Cell death: critical control points. Cell 2004; 116:205-219. This offers a comprehensive review of pro and antiapoptotic factors and how they function to regulate apopotic pathways.
30. Kobayashi SD, Braughton KR, Whitney AR, et al. Bacterial pathogens modulate an apoptosis differentiation program in human neutrophils. Proc Natl Acad Sci USA 2003; 100:10948-10953.
31. Kobayashi SD, Deleo FR. An apoptosis differentiation programme in human polymorphonuclear leucocytes. Biochem Soc Trans 2004; 32:474-476. This review summarizes this group's findings that neutrophils undergo global changes in gene expression that constitute an apoptosis differentiation program, which regulates the final stage of transcription-regulated neutrophil maturation.
32. Yoshiie K, Kim HY, Mott J, Rikihisa Y. Intracellular infection by the human granulocytic ehrlichiosis agent inhibits human neutrophil apoptosis. Infect Immun 2000; 68:1125-1133.
33. Scaife H, Woldehiwet Z, Hart CA, Edwards SW. Anaplasma phagocytophilum reduces neutrophil apoptosis in vivo. Infect Immun 2003; 71:1995-2001.
34. ••] that A. phagocytophilum alters host cell expression of pro and antiapoptotic genes.
35. Sukumaran B, Carlyon JA, Cai J, et al. Early transcriptional response of human neutrophils to Anaplasma phagocytophilum infection. Infect Immun (in press).
36. Ge Y, Yoshiie K, Kuribayashi F, et al. Anaplasma phagocytophilum inhibits human neutrophil apoptosis via upregulation of bfl-1, maintenance of mitochondrial membrane potential and prevention of caspase 3 activation. Cell Microbiol 2005; 7:29-38. This paper provides functional evidence for a contributory mechanism by which A. phagocytophilum delays neutrophil apoptosis. Maintenance of bfl-1 leads to the preservation of mitochondrial membrane potential, which translates to a delay in caspase 3 activation.